Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Respect women, promote health and reduce stigma: ethical arguments for universal hepatitis C screening in pregnancy.

Gross MS, Ruth AR, Rasmussen SA.

J Med Ethics. 2020 Feb 13. pii: medethics-2019-105692. doi: 10.1136/medethics-2019-105692. [Epub ahead of print]

PMID:
32054774
2.

Time- and intensity-dependent broadband cavity-enhanced absorption spectroscopy with pulsed intra-cavity laser-induced plasmas.

Keary BP, Ruth AA.

Opt Express. 2019 Dec 9;27(25):36864-36874. doi: 10.1364/OE.27.036864.

PMID:
31873458
3.

Off-Axis Cavity-Enhanced Absorption Spectroscopy of 14NH3 in Air Using a Gain-Switched Frequency Comb at 1.514 μm.

Chandran S, Ruth AA, Martin EP, Alexander JK, Peters FH, Anandarajah PM.

Sensors (Basel). 2019 Nov 28;19(23). pii: E5217. doi: 10.3390/s19235217.

4.

Trauma-Responsive Care in a Pediatric Setting: Feasibility and Acceptability of Screening for Adverse Childhood Experiences.

Kia-Keating M, Barnett ML, Liu SR, Sims GM, Ruth AB.

Am J Community Psychol. 2019 Dec;64(3-4):286-297. doi: 10.1002/ajcp.12366. Epub 2019 Aug 2.

PMID:
31373039
5.

Acquired von Willebrand Syndrome in Pediatric Extracorporeal Membrane Oxygenation Patients: A Single Institution's Experience.

Ruth A, Meador M, Hui R, Loftis L, Teruya J.

Pediatr Crit Care Med. 2019 Oct;20(10):980-985. doi: 10.1097/PCC.0000000000002009.

PMID:
31246745
6.

An empirical model on the impact of foreign direct investment on China's environmental pollution: analysis based on simultaneous equations.

Ayamba EC, Haibo C, Ibn Musah AA, Ruth A, Osei-Agyemang A.

Environ Sci Pollut Res Int. 2019 Jun;26(16):16239-16248. doi: 10.1007/s11356-019-04991-9. Epub 2019 Apr 10.

PMID:
30972677
7.

New Kid on the Block? Is Amino-Terminal Pro-B-Type Natriuretic Peptide Ready for the Big Time?

Ruth A, Akcan-Arikan A.

Pediatr Crit Care Med. 2019 Feb;20(2):201-202. doi: 10.1097/PCC.0000000000001780. No abstract available.

PMID:
30720657
8.

OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.

Odobasic D, Ruth AJ, Oudin V, Kitching AR, Holdsworth SR.

Nephrol Dial Transplant. 2019 Mar 1;34(3):429-441. doi: 10.1093/ndt/gfy177.

PMID:
29939347
9.

Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.

Earley W, Durgam S, Lu K, Ruth A, Németh G, Laszlovszky I, Yatham LN.

J Affect Disord. 2018 Jan 15;226:239-244. doi: 10.1016/j.jad.2017.09.040. Epub 2017 Sep 25.

10.

Establishment of Larval Zebrafish as an Animal Model to Investigate Trypanosoma cruzi Motility In Vivo.

Akle V, Agudelo-Dueñas N, Molina-Rodriguez MA, Kartchner LB, Ruth AM, González JM, Forero-Shelton M.

J Vis Exp. 2017 Sep 30;(127). doi: 10.3791/56238.

11.

Molybdenum Carbamate Nanosheets as a New Class of Potential Phase Change Materials.

Zhukovskyi M, Plashnitsa V, Petchsang N, Ruth A, Bajpai A, Vietmeyer F, Wang Y, Brennan M, Pang Y, Werellapatha K, Bunker B, Chattopadhyay S, Luo T, Janko B, Fay P, Kuno M.

Nano Lett. 2017 Jun 14;17(6):3902-3906. doi: 10.1021/acs.nanolett.7b01464. Epub 2017 May 22.

PMID:
28510441
12.

A LC-MS All-in-One Workflow for Site-Specific Location, Identification and Quantification of N-/O- Glycosylation in Human Chorionic Gonadotropin Drug Products.

Zhu H, Qiu C, Ruth AC, Keire DA, Ye H.

AAPS J. 2017 May;19(3):846-855. doi: 10.1208/s12248-017-0062-z. Epub 2017 Feb 28.

PMID:
28247191
13.

Fluorescence intermittency originates from reclustering in two-dimensional organic semiconductors.

Ruth A, Hayashi M, Zapol P, Si J, McDonald MP, Morozov YV, Kuno M, Jankó B.

Nat Commun. 2017 Feb 22;8:14521. doi: 10.1038/ncomms14521.

14.

"Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products".

Fuenffinger N, Ritchie M, Ruth A, Gryniewicz-Ruzicka C.

J Pharm Biomed Anal. 2017 Feb 5;134:282-286. doi: 10.1016/j.jpba.2016.11.055. Epub 2016 Dec 2.

PMID:
27951469
15.

A Retrospective Evaluation of the Use of Mass Spectrometry in FDA Biologics License Applications.

Rogstad S, Faustino A, Ruth A, Keire D, Boyne M, Park J.

J Am Soc Mass Spectrom. 2017 May;28(5):786-794. doi: 10.1007/s13361-016-1531-9. Epub 2016 Nov 21.

PMID:
27873217
16.

Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone.

Khan A, Durgam S, Tang X, Ruth A, Mathews M, Gommoll CP.

Prim Care Companion CNS Disord. 2016 Apr 28;18(2). doi: 10.4088/PCC.15m01904. eCollection 2016.

17.

Diamond-like-carbon nanoparticle production and agglomeration following UV multi-photon excitation of static naphthalene/helium gas mixtures.

Walsh AJ, Tielens AG, Ruth AA.

J Chem Phys. 2016 Jul 14;145(2):024303. doi: 10.1063/1.4955192.

PMID:
27421401
18.

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies.

Clayton AH, Durgam S, Tang X, Chen C, Ruth A, Gommoll C.

Neuropsychiatr Dis Treat. 2016 Jun 21;12:1467-76. doi: 10.2147/NDT.S103408. eCollection 2016.

19.
20.

Locomotor pattern fails to predict foramen magnum angle in rodents, strepsirrhine primates, and marsupials.

Ruth AA, Raghanti MA, Meindl RS, Lovejoy CO.

J Hum Evol. 2016 May;94:45-52. doi: 10.1016/j.jhevol.2016.01.003. Epub 2016 Mar 12.

PMID:
27178457
21.

Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.

Durgam S, Cutler AJ, Lu K, Migliore R, Ruth A, Laszlovszky I, Németh G, Meltzer HY.

J Clin Psychiatry. 2015 Dec;76(12):e1574-82. doi: 10.4088/JCP.15m09997.

22.

Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.

Cutler AJ, Gommoll CP, Chen C, Greenberg WM, Ruth A.

Prim Care Companion CNS Disord. 2015 Jun 11;17(3). doi: 10.4088/PCC.14m01753. eCollection 2015.

23.

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.

Freeman MP, Fava M, Gommoll C, Chen C, Greenberg WM, Ruth A.

Int Clin Psychopharmacol. 2016 Mar;31(2):100-9. doi: 10.1097/YIC.0000000000000104.

24.

Extracorporeal therapies in pediatric severe sepsis: findings from the pediatric health-care information system.

Ruth A, McCracken CE, Fortenberry JD, Hebbar KB.

Crit Care. 2015 Nov 10;19:397. doi: 10.1186/s13054-015-1105-4.

25.

Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.

Vieta E, Durgam S, Lu K, Ruth A, Debelle M, Zukin S.

Eur Neuropsychopharmacol. 2015 Nov;25(11):1882-91. doi: 10.1016/j.euroneuro.2015.08.020. Epub 2015 Sep 5.

26.

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.

Kane JM, Zukin S, Wang Y, Lu K, Ruth A, Nagy K, Laszlovszky I, Durgam S.

J Clin Psychopharmacol. 2015 Aug;35(4):367-73. doi: 10.1097/JCP.0000000000000346.

PMID:
26075487
27.

The authors reply.

Ruth A, McCracken C, Fortenberry JD, Hebbar K.

Pediatr Crit Care Med. 2015 May;16(4):391-2. doi: 10.1097/PCC.0000000000000393. No abstract available.

PMID:
25946272
28.

Laser-induced plasmas in ambient air for incoherent broadband cavity-enhanced absorption spectroscopy.

Ruth AA, Dixneuf S, Orphal J.

Opt Express. 2015 Mar 9;23(5):6092-101. doi: 10.1364/OE.23.006092.

PMID:
25836833
29.

Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.

Calabrese JR, Keck PE Jr, Starace A, Lu K, Ruth A, Laszlovszky I, Németh G, Durgam S.

J Clin Psychiatry. 2015 Mar;76(3):284-92. doi: 10.4088/JCP.14m09081.

30.

Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.

Sachs GS, Greenberg WM, Starace A, Lu K, Ruth A, Laszlovszky I, Németh G, Durgam S.

J Affect Disord. 2015 Mar 15;174:296-302. doi: 10.1016/j.jad.2014.11.018. Epub 2014 Nov 24.

31.
32.

Evaluation of functional health and well-being in patients receiving levomilnacipran ER for the treatment of major depressive disorder.

Blum SI, Tourkodimitris S, Ruth A.

J Affect Disord. 2015 Jan 1;170:230-6. doi: 10.1016/j.jad.2014.09.005. Epub 2014 Sep 10.

33.

Pediatric severe sepsis: current trends and outcomes from the Pediatric Health Information Systems database.

Ruth A, McCracken CE, Fortenberry JD, Hall M, Simon HK, Hebbar KB.

Pediatr Crit Care Med. 2014 Nov;15(9):828-38. doi: 10.1097/PCC.0000000000000254.

PMID:
25226500
34.

Stigmatized neighborhoods, social bonding, and health.

Wutich A, Ruth A, Brewis A, Boone C.

Med Anthropol Q. 2014 Dec;28(4):556-77. doi: 10.1111/maq.12124. Epub 2014 Sep 8.

PMID:
25196035
35.

The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.

Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I.

Bipolar Disord. 2015 Feb;17(1):63-75. doi: 10.1111/bdi.12238. Epub 2014 Jul 24.

36.

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder.

Thase ME, Chen D, Edwards J, Ruth A.

Int Clin Psychopharmacol. 2014 Nov;29(6):351-6. doi: 10.1097/YIC.0000000000000045.

37.

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: a phase II, randomized clinical trial.

Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I.

Schizophr Res. 2014 Feb;152(2-3):450-7. doi: 10.1016/j.schres.2013.11.041. Epub 2014 Jan 10.

38.

Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression.

Khan A, Sambunaris A, Edwards J, Ruth A, Robinson DS.

Int Clin Psychopharmacol. 2014 Mar;29(2):86-92. doi: 10.1097/YIC.0000000000000016.

39.

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlled study.

Montgomery SA, Mansuy L, Ruth AC, Li D, Gommoll C.

Int Clin Psychopharmacol. 2014 Jan;29(1):26-35. doi: 10.1097/YIC.0000000000000009.

40.

Molecular iodine (I2) emission from two Laminaria species (Phaeophyceae) and impact of irradiance and temperature on I2 emission into air and iodide release into seawater from Laminaria digitata.

Nitschke U, Dixneuf S, Ruth AA, Schmid M, Stengel DB.

Mar Environ Res. 2013 Dec;92:102-9. doi: 10.1016/j.marenvres.2013.09.006. Epub 2013 Sep 17.

PMID:
24080409
41.

Multi-photon UV photolysis of gaseous polycyclic aromatic hydrocarbons: extinction spectra and dynamics.

Walsh AJ, Ruth AA, Gash EW, Mansfield MW.

J Chem Phys. 2013 Aug 7;139(5):054304. doi: 10.1063/1.4816003.

PMID:
23927259
42.
43.

Hollow core photonic crystal fiber based viscometer with Raman spectroscopy.

Horan LE, Ruth AA, Gunning FC.

J Chem Phys. 2012 Dec 14;137(22):224504. doi: 10.1063/1.4771659.

PMID:
23249014
44.

SDCCAG8 obesity alleles and reduced weight loss after a lifestyle intervention in overweight children and adolescents.

Scherag A, Kleber M, Boes T, Kolbe AL, Ruth A, Grallert H, Illig T, Heid IM, Toschke AM, Grau K; NUGENOB Consortium, Sørensen TI, Hebebrand J, Hinney A, Reinehr T.

Obesity (Silver Spring). 2012 Feb;20(2):466-70. doi: 10.1038/oby.2011.339. Epub 2011 Nov 17.

45.

Fluorescence excitation and excited state intramolecular proton transfer of jet-cooled naphthol derivatives: part 2. 2-Hydroxy-1-naphthaldehyde.

McCarthy A, Ruth AA.

Phys Chem Chem Phys. 2011 Nov 7;13(41):18661-70. doi: 10.1039/c1cp22200g. Epub 2011 Sep 23.

PMID:
21947217
46.

Fluorescence excitation and excited state intramolecular proton transfer of jet-cooled naphthol derivatives: Part 1. 1-Hydroxy-2-naphthaldehyde.

McCarthy A, Ruth AA.

Phys Chem Chem Phys. 2011 Apr 28;13(16):7485-99. doi: 10.1039/c0cp02601h. Epub 2011 Mar 21.

PMID:
21423923
47.

Molecular iodine emission rates and photosynthetic performance of different thallus parts of Laminaria digitata (Phaeophyceae) during emersion.

Nitschke U, Ruth AA, Dixneuf S, Stengel DB.

Planta. 2011 Apr;233(4):737-48. doi: 10.1007/s00425-010-1334-3. Epub 2010 Dec 28.

PMID:
21188416
48.

Skin nodules in a 16-year-old adolescent with acute lymphoblastic leukemia.

Ruth A, Sabio H, McLean TW, Manavi C, Palavecino EL, Shetty AK.

Can J Infect Dis Med Microbiol. 2009 Spring;20(1):e8-9. No abstract available.

49.

An alternative model for the provision of services to HIV-positive orphans in Haiti.

Romero-Daza N, Ruth A, Denis-Luque M, Luque JS.

J Health Care Poor Underserved. 2009;20(4 Suppl):36-40. doi: 10.1353/hpu.0.0214. No abstract available.

PMID:
20168031
50.

Reproductive health experiences among women with physical disabilities in the Northwest Region of Cameroon.

Bremer K, Cockburn L, Ruth A.

Int J Gynaecol Obstet. 2010 Mar;108(3):211-3. doi: 10.1016/j.ijgo.2009.10.008. Epub 2009 Dec 1.

PMID:
19951820

Supplemental Content

Support Center